Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidehiko Suzuki

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Experimental Lung Research|June 4, 2002
Suppressive effect of pulmonary hypertension and leukocyte activation by inhaled prostaglandin E1 in rats with monocrotaline-induced pulmonary hypertensionShiro Kato, Hiroyuki Sugimura, Izumi Kishiro, et al.
International Immunology|April 30, 2020
Impaired mucociliary motility enhances antigen-specific nasal IgA immune responses to a cholera toxin-based nasal vaccineHuangwenxian Lan, Hidehiko Suzuki, Takahiro Nagatake, et al.
International Immunopharmacology|June 27, 2018
Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in miceRui Tada, Hidehiko Suzuki, Saeko Takahashi, et al.
Biomaterials|October 11, 2011
The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in miceHidehiko Suzuki, Masuo Kondoh, Hideki Kakutani, et al.
Pharmaceutics|April 30, 2021
Polymeric Caffeic Acid Acts as a Nasal Vaccine Formulation against <i>Streptococcus pneumoniae</i> Infections in MiceRui Tada, Hidehiko Suzuki, Miki Ogasawara, et al.
Vaccine|August 3, 2021
Fusion of parvovirus B19 receptor-binding domain and pneumococcal surface protein A induces protective immunity against parvovirus B19 and Streptococcus pneumoniaeHidehiko Suzuki, Takafumi Noguchi, Keiji Ogawa, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|January 27, 2016
Applying low-intensity pulsed ultrasounds (LIPUS) to a zoledronate-associated atypical femoral shaft fracture without cessation of zoledronate therapy for 3 years follow up: a case reportShoutaro Arakawa, Mitsuru Saito, Makoto Kubota, et al.
Plos One|May 29, 2015
C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal VaccineHidehiko Suzuki, Akihiro Watari, Eri Hashimoto, et al.
Microbiology and Immunology|November 15, 2024
Efficient Neutralizing Antibodies Induction by Human Parvovirus B19 Epitope-Presenting Protein NanoparticlesSakika Kimura, Hidehiko Suzuki, Yu Hatakeyama, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 6, 2010
A claudin-targeting molecule as an inhibitor of tumor metastasisRie Saeki, Masuo Kondoh, Hideki Kakutani, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Experimental Lung Research|June 4, 2002
Suppressive effect of pulmonary hypertension and leukocyte activation by inhaled prostaglandin E1 in rats with monocrotaline-induced pulmonary hypertensionShiro Kato, Hiroyuki Sugimura, Izumi Kishiro, et al.
International Immunology|April 30, 2020
Impaired mucociliary motility enhances antigen-specific nasal IgA immune responses to a cholera toxin-based nasal vaccineHuangwenxian Lan, Hidehiko Suzuki, Takahiro Nagatake, et al.
International Immunopharmacology|June 27, 2018
Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in miceRui Tada, Hidehiko Suzuki, Saeko Takahashi, et al.
Biomaterials|October 11, 2011
The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in miceHidehiko Suzuki, Masuo Kondoh, Hideki Kakutani, et al.
Pharmaceutics|April 30, 2021
Polymeric Caffeic Acid Acts as a Nasal Vaccine Formulation against <i>Streptococcus pneumoniae</i> Infections in MiceRui Tada, Hidehiko Suzuki, Miki Ogasawara, et al.
Vaccine|August 3, 2021
Fusion of parvovirus B19 receptor-binding domain and pneumococcal surface protein A induces protective immunity against parvovirus B19 and Streptococcus pneumoniaeHidehiko Suzuki, Takafumi Noguchi, Keiji Ogawa, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|January 27, 2016
Applying low-intensity pulsed ultrasounds (LIPUS) to a zoledronate-associated atypical femoral shaft fracture without cessation of zoledronate therapy for 3 years follow up: a case reportShoutaro Arakawa, Mitsuru Saito, Makoto Kubota, et al.
Plos One|May 29, 2015
C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal VaccineHidehiko Suzuki, Akihiro Watari, Eri Hashimoto, et al.
Microbiology and Immunology|November 15, 2024
Efficient Neutralizing Antibodies Induction by Human Parvovirus B19 Epitope-Presenting Protein NanoparticlesSakika Kimura, Hidehiko Suzuki, Yu Hatakeyama, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 6, 2010
A claudin-targeting molecule as an inhibitor of tumor metastasisRie Saeki, Masuo Kondoh, Hideki Kakutani, et al.
Pageof 5